---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-001154"
form_type: "8-K"
ticker: "CTEV"
cik: "0001793229"
company_name: "Claritev Corp"
filed_at: "2024-01-04T23:59:59+00:00"
generated_at: "2026-06-07T04:09:17.782886+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# MultiPlan names Travis Dalton as CEO effective March 1, 2024; Dale White becomes Executive Chair

## Summary
- Travis Dalton to succeed Dale White as President and CEO on or around March 1, 2024; Dalton previously GM of Oracle Health.
- Dale White to become Executive Chair, succeeding Mark Tabak; White remains an employee and receives a $1.5M severance package.
- Dalton receives base salary $825,000, sign-on bonus $500,000, target bonus 125%, and equity grants valued over $13M.
- Board size increased from 12 to 13 directors; Dalton appointed as Class I director until 2024 annual meeting.
- White will receive executive chair base salary of $487,500 and equity grant of $750,000 in fiscal 2024.

## SEC filing metadata
- accession: 0001104659-24-001154
- form_type: 8-K
- ticker: CTEV
- cik: 0001793229
- company_name: Claritev Corp
- filed_at: 2024-01-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1793229/000110465924001154/0001104659-24-001154-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1793229/000110465924001154/tm2333690d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-001154
- JSON: https://secwatch.observer/filing/0001104659-24-001154.json
- Plain text: https://secwatch.observer/filing/0001104659-24-001154.txt

## Key facts
- Executive change
  Dale White changed role as Executive Chair of the Board at Claritev Corp.
  - Action: transitioned to
  - Role: Executive Chair of the Board
  source text: On the Transition Date, Mr. White will remain an employee of the Company and be appointed the Executive Chair of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1793229/000110465924001154/0001104659-24-001154-index.htm
- Executive change
  Mark Tabak changed role as Non-Executive Chair of the Board at Claritev Corp.
  - Action: stepped down from
  - Role: Non-Executive Chair of the Board
  source text: Mark Tabak, the Company’s Non-Executive Chair of the Board, will step down from such role, effective as of the Transition Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1793229/000110465924001154/0001104659-24-001154-index.htm
- Executive change
  Travis Dalton was appointed as President and Chief Executive Officer at Claritev Corp.
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: Mr. Dalton will become the Company’s President and Chief Executive Officer succeeding Dale White on or around March 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1793229/000110465924001154/0001104659-24-001154-index.htm
- Executive change
  Travis Dalton was appointed as Class I Director at Claritev Corp.
  - Action: appointed
  - Role: Class I Director
  source text: On the Transition Date, Mr. Dalton will be appointed as a Class I Director of the Board to fill the vacancy created by the Board Size Increase
  evidence_url: https://www.sec.gov/Archives/edgar/data/1793229/000110465924001154/0001104659-24-001154-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.